Fibrinogenalphachain抗体;Fibrinogenalphachain Antibody—艾普蒂 新品

+ +

•  

   

     Western blot analysis of Fibrinogen alpha chain expression in Human plasma lysate.    

  
  

The fibrinogen alpha chain (FGA) is a critical component of fibrinogen, a plasma glycoprotein essential for blood coagulation. Produced primarily in the liver, fibrinogen consists of two sets of three polypeptide chains (Aα, Bβ, and γ) linked by disulfide bonds. The alpha chain, encoded by the *FGA* gene, contains thrombin-cleaved sites that release fibrinopeptide A during clot formation, initiating polymerization into fibrin matrices. Fibrinogen alpha chain antibodies are immunodetection tools targeting epitopes on this chain, widely used in research and diagnostics to study fibrinogen structure, function, and disorders.

These antibodies help identify abnormalities in fibrinogen synthesis, processing, or degradation, aiding in diagnosing congenital disorders like hypofibrinogenemia or dysfibrinogenemia. They also contribute to research on thrombotic diseases, as elevated fibrinogen levels correlate with cardiovascular risk. Additionally, fibrinogen alpha chain antibodies are utilized in studying inflammatory conditions, cancer progression, and wound healing, given fibrinogen's role in cellular adhesion, angiogenesis, and tissue repair.

Commercial FGA antibodies are typically validated via ELISA, Western blot, or immunohistochemistry. Cross-reactivity with homologs in other species (e.g., mouse, rat) is common, enabling translational studies. However, specificity validation is crucial due to structural similarities between fibrinogen chains and potential isoforms. Understanding FGA antibody characteristics supports advancements in hematology, vascular biology, and therapeutic development targeting coagulation pathways.